Results 131 to 140 of about 43,190 (225)

Randomized, placebo-controlled phase 3 trial evaluating safety, immunogenicity, and reactogenicity of RSVPreF3-Mat in high-risk pregnant women and their infants. [PDF]

open access: yesHum Vaccin Immunother
Bebia Z   +14 more
europepmc   +1 more source

Optimizing Health Insurance Claims Processing: The Role of Clinical Documentation Improvement (CDI). [PDF]

open access: yesRisk Manag Healthc Policy
Alumran A   +5 more
europepmc   +1 more source

Validity of diagnostic codes used to ascertain maternal injuries during pregnancy. [PDF]

open access: yesAm J Epidemiol
Ahmed AM   +5 more
europepmc   +1 more source

[Puerperium].

open access: yesGaceta medica de Mexico, 1976
C, MacGregor   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy